Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anish Scaria

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|February 14, 2022
Blood Eosinophils in Chinese COPD Participants and Response to Treatment with Combination Low-Dose Theophylline and Prednisone: A Post-Hoc Analysis of the TASCS TrialThomas Bradbury, Gian Luca Di Tanna, Anish Scaria, et al.
Journal of Cardiac Failure|September 5, 2020
Response to: Loutradis et al. Longer Dialysis Sessions Improve Cardiac Systolic Function by Reducing Myocardial StunningBrendan Smyth, Christopher T Chan, Stuart M Grieve, et al.
Journal of Cardiac Failure|April 18, 2020
Predictors of Change in Left-Ventricular Structure and Function in a Trial of Extended Hours HemodialysisBrendan Smyth, Christopher T Chan, Stuart M Grieve, et al.
Internal Medicine Journal|October 4, 2020
Risk factors for incident kidney disease in older adults: an Australian prospective population-based studyAmy Kang, Louisa Sukkar, Carinna Hockham, et al.
BMC Nephrology|July 14, 2019
Effect of extended hours dialysis on markers of chronic kidney disease-mineral and bone disorder in the ACTIVE Dialysis studyZhipeng Zhan, Brendan Smyth, Nigel D Toussaint, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 2016
The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study: A Randomized Controlled TrialMatthew A Roberts, Helen L Pilmore, Francesco L Ierino, et al.
The Lancet. Infectious Diseases|October 15, 2013
Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trialDavid W Johnson, Sunil V Badve, Elaine M Pascoe, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 14, 2014
A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trialDavid W Johnson, Elaine M Pascoe, Sunil V Badve, et al.
Nephrology (Carlton, Vic.)|July 25, 2015
Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) studyAndrea K Viecelli, Elaine M Pascoe, Kevan R Polkinghorne, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 31, 2015
The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot TrialLei Zhang, Sunil V Badve, Elaine M Pascoe, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
International Journal of Chronic Obstructive Pulmonary Disease|February 14, 2022
Blood Eosinophils in Chinese COPD Participants and Response to Treatment with Combination Low-Dose Theophylline and Prednisone: A Post-Hoc Analysis of the TASCS TrialThomas Bradbury, Gian Luca Di Tanna, Anish Scaria, et al.
Journal of Cardiac Failure|September 5, 2020
Response to: Loutradis et al. Longer Dialysis Sessions Improve Cardiac Systolic Function by Reducing Myocardial StunningBrendan Smyth, Christopher T Chan, Stuart M Grieve, et al.
Journal of Cardiac Failure|April 18, 2020
Predictors of Change in Left-Ventricular Structure and Function in a Trial of Extended Hours HemodialysisBrendan Smyth, Christopher T Chan, Stuart M Grieve, et al.
Internal Medicine Journal|October 4, 2020
Risk factors for incident kidney disease in older adults: an Australian prospective population-based studyAmy Kang, Louisa Sukkar, Carinna Hockham, et al.
BMC Nephrology|July 14, 2019
Effect of extended hours dialysis on markers of chronic kidney disease-mineral and bone disorder in the ACTIVE Dialysis studyZhipeng Zhan, Brendan Smyth, Nigel D Toussaint, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 2016
The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study: A Randomized Controlled TrialMatthew A Roberts, Helen L Pilmore, Francesco L Ierino, et al.
The Lancet. Infectious Diseases|October 15, 2013
Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trialDavid W Johnson, Sunil V Badve, Elaine M Pascoe, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 14, 2014
A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trialDavid W Johnson, Elaine M Pascoe, Sunil V Badve, et al.
Nephrology (Carlton, Vic.)|July 25, 2015
Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) studyAndrea K Viecelli, Elaine M Pascoe, Kevan R Polkinghorne, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 31, 2015
The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot TrialLei Zhang, Sunil V Badve, Elaine M Pascoe, et al.
Pageof 4